Skip to contentTISCH ANDREW H — LOEWS CORP insider: 447 transactions · InsiderLensTISCH ANDREW H
- Director at CNA FINANCIAL CORP · on record since Feb 23, 2006
- Director at LOEWS CORP · on record since Feb 2, 2006
- 10% owner at NEUROGEN CORP · on record since Apr 21, 2004
- DIRECTOR EMERITUS at LOEWS CORP · on record since Jan 6, 2025
- Director at K12 INC · on record since Dec 12, 2007
- Chairman of the Board at K12 INC · on record since Dec 12, 2007
- Director at Boardwalk Pipeline Partners, LP · on record since Jun 30, 2008
- Director at DIAMOND OFFSHORE DRILLING INC · on record since May 26, 2011
- 10% owner at TRIMERIS INC · on record since Nov 8, 2011
- 10% owner at CELLEGY PHARMACEUTICALS INC · on record since Jul 29, 2004
- 10% owner at INCYTE CORP · on record since Jan 16, 2004
- Ch. Ex. Comm./Off. Pres. at LOEWS CORP · on record since Jan 20, 2004
- No longer 10% owner. at INCYTE CORP · on record since Aug 13, 2004
- 10% owner at NOFIRE TECHNOLOGIES INC · on record since Dec 28, 2004
Insider trading activity of TISCH ANDREW H
- Transactions on record
- 447
- since Jan 16, 2004
- Open-market buys
- 16
- $3.8M
- Open-market sells
- 70
- $179.3M
- Companies traded
- 9
- last filing Mar 13, 2026
Figures computed from official regulatory filings — methodology.
Companies where TISCH ANDREW H has traded
- LOEWS CORP337 tx · $332.3M · Mar 13, 2026
- DIAMOND OFFSHORE DRILLING INC35 tx · Jan 2, 2020
- Boardwalk Pipeline Partners, LP11 tx · $2.5M · Jul 19, 2018
- K12 INC44 tx · $7.7M · Apr 27, 2017
- CNA FINANCIAL CORP2 tx · $2.3M · Nov 20, 2009
- NOFIRE TECHNOLOGIES INC4 tx · Dec 28, 2004
- INCYTE CORP11 tx · Aug 13, 2004
- CELLEGY PHARMACEUTICALS INC2 tx · Jul 29, 2004
- NEUROGEN CORP1 tx · Apr 21, 2004
Track record of TISCH ANDREW H
Statistical track record
Free- Open-market buys
- 17
- Last buy
- Nov 19, 2009
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of TISCH ANDREW H
Co-insiders of TISCH ANDREW H
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Baker Bros. Capital (GP), LLCINCYTE CORP +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Mar 13, 2026 | Sell | -199 | 109.44 USD | $21.8K | SEC |
| Mar 13, 2026 | Sell | -24,801 | 108.67 USD | $2.7M | SEC |
| Mar 13, 2026 | Sell | -199 | 109.44 USD | $21.8K | SEC |
| Mar 13, 2026 | Sell | -24,801 | 108.67 USD | $2.7M | SEC |
| Mar 13, 2026 | Sell | -50,000 | 108.81 USD | $5.4M | SEC |
| Feb 17, 2026 | Sell | -50,000 | 108.87 USD | $5.4M | SEC |
| Feb 17, 2026 | Sell | -50,000 | 110.27 USD | $5.5M | SEC |
| Dec 17, 2025 | Sell | -50,000 | 105.07 USD | $5.3M | SEC |
| Dec 8, 2025 | Sell | -23,485 | 104.62 USD | $2.5M | SEC |
| Dec 8, 2025 | Sell | -6,515 | 105.48 USD | $687.2K | SEC |
| Dec 3, 2025 | Sell | -15,991 | 107.71 USD | $1.7M | SEC |
| Dec 3, 2025 | Sell | -24,009 | 106.61 USD | $2.6M | SEC |
| Dec 3, 2025 | Sell | -10,000 | 105.57 USD | $1.1M | SEC |
| Dec 3, 2025 | Sell | -20,000 | 105.57 USD | $2.1M | SEC |
| May 30, 2025 | Other | 565,706 | 88.39 USD | $50M | SEC |
| May 30, 2025 | Other | -565,706 | 88.39 USD | $50M | SEC |
| Jan 6, 2025 | ExerciseD | -15,000 | 0.00 USD | $0 | SEC |
| Jan 6, 2025 | Exercise | 15,000 | 38.46 USD | $576.9K | SEC |
| Jan 6, 2025 | Other | -21,341 | 85.02 USD | $1.8M | SEC |
| Jan 6, 2025 | Sell | -7,533 | 84.35 USD | $635.4K | SEC |
| Jan 6, 2025 | Sell | -8,659 | 84.94 USD | $735.5K | SEC |
| Jan 6, 2025 | Other | -22,467 | 84.61 USD | $1.9M | SEC |
| Jan 6, 2025 | ExerciseD | -15,000 | 0.00 USD | $0 | SEC |
| Jan 6, 2025 | ExerciseD | -15,000 | 0.00 USD | $0 | SEC |
| Jan 6, 2025 | Exercise | 15,000 | 35.52 USD | $532.8K | SEC |